A study revealed a paradox: patients with *moderate* financial toxicity had the highest out-of-pocket payments. Those with *severe* toxicity had the most "write-offs" or bad debt. This indicates the worst financial distress isn't just about what patients pay, but what they are unable to pay.

Preventing a chronic disease like type 2 diabetes saves hundreds of thousands of dollars per patient. However, due to high customer churn and standard one-year contracts, insurance companies see no long-term financial upside in prevention, as another company will likely benefit from their investment.

Contrary to the narrative of government inefficiency, Medicare's administrative overhead is only 2%. In contrast, private commercial insurers spend 16% of every dollar on administration, advertising, and claim disputes, revealing a major source of bloat in the US healthcare system.

Many large businesses fail to implement ideal, one-click payment recovery systems because revenue teams lack engineering resources and the financial impact isn't salient to executives. This inaction can cost tens of millions of dollars for want of a few days of work.

Startups consistently underestimate sales cycles with large hospital systems. Due to risk aversion and complex approval processes designed to ensure patient safety, what seems like a three-month process will likely take nine months. Founders must build this 3x buffer into their financial planning to survive.

Widespread cancellation of medical debt, while well-intentioned, may remove consumer pressure on providers. If patients don't need to shop around or question prices because they anticipate forgiveness, it eliminates a key market force needed to control escalating costs.

The economic case for a prophylactic drug isn't just clinical. Its real value is enabling expensive, multi-week inpatient procedures (like CAR-T side effect observation) to become outpatient treatments, freeing up hospital beds and massively reducing healthcare system costs.

Insurance firms intentionally create friction, like forcing phone calls with long hold times, to discourage hospitals from pursuing all claims. This tactic protects their profits to such an extent that UnitedHealthcare's investors sued when the company tried to make the claims process easier for providers.

When selling to hospitals, solutions that directly increase or recover revenue are far more compelling than those that only promise time savings. Hospital buying psychology is geared toward immediate financial impact, and some legacy billing models can even disincentivize adopting efficiency-only tools.